About Helico
Helico is a company based in Auckland (New Zealand) founded in 2020 by Wayman Puna. Helico has raised $1.26 million across 1 funding round from investors including Icehouse Ventures, Wolfgang Leitner and David Ross. Helico offers products and services including BioVerge Platform, SeqOptima, and Verdantix. Helico operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Twist Bioscience, among others.
- Headquarter Auckland, New Zealand
- Founders Wayman Puna
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.26 M (USD)
in 1 rounds
-
Latest Funding Round
$1.26 M (USD), Seed
May 18, 2022
-
Investors
Icehouse Ventures
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Helico
Helico offers a comprehensive portfolio of products and services, including BioVerge Platform, SeqOptima, and Verdantix.
Plant-based system for high-yield biologics manufacturing and validation.
Technology for enhancing genetic sequences in plant hosts.
Tool for optimizing protein production in plants.
Funding Insights of Helico
Helico has successfully raised a total of $1.26M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.26 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Helico
Helico has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Icehouse Ventures, Wolfgang Leitner and David Ross.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE fund focused on high growth companies of New Zealand
|
Locked | Locked | Locked | |
|
WL
Wolfgang Leitner |
-
|
Locked | Locked | Locked |
|
DR
David Ross |
Indian angel investor focusing on early-stage tech startups and innovation.
|
Locked | Locked | Locked |
Investor details for Helico
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Helico
Investment portfolio details for Helico
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Helico
Detailed financials for Helico
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Helico Comparisons
Peer comparison for Helico
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Helico
Helico operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Twist Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
Detailed competitors of Helico
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Helico
Complete news archive for Helico
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Helico
Helico was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Helico is headquartered in Auckland, New Zealand.
Helico is a funded company, having raised a total of $1.26M across 1 funding round to date.
Helico was founded in 2020 and is based in Auckland, New Zealand. A computational modeling tool is offered by the company within the biotechnology sector, focusing on drug discovery and development. Biochemical interactions in plants are analyzed and predicted through this tool, supporting research and innovation in plant-derived pharmaceuticals. Operations center on software-based simulations to aid scientific workflows.
Helico offers BioVerge Platform, SeqOptima, and Verdantix.
Helico has 3 investors. Key investors include Icehouse Ventures, Wolfgang Leitner, and David Ross.